Management of sinonasal tumors: prognostic factors and outcomes: a 10 year experience at a tertiary care hospital
- PMID: 24427634
- PMCID: PMC3718929
- DOI: 10.1007/s12070-013-0650-x
Management of sinonasal tumors: prognostic factors and outcomes: a 10 year experience at a tertiary care hospital
Abstract
Sinonasal malignancies are said to be a highly heterogeneous group of cancers, accounting for less than 1 % of all cancers and less than 3 % of all upper aerodigestive tract tumors. Originating from any histologic components of the sinonasal cavity, the histopathology of these tumors is diverse. Accordingly, treatment options vary, surgery being the mainstay in most of them. Recurrence rates differs with each histological type of tumor, dependent on various factors. In this article, we have tried to identify the prevalent characteristics of sinonasal malignancies and to outline the prognostic factors affecting the outcome. It is a retrospective study design with a total number of 102 patients. Patients diagnosed with sinonasal malignancies were included and any patient previously operated outside our institute or having received prior radiation or chemotherapy were excluded. The patients were selected over a period of 10 years, from 2000 to 2010. Data was analyzed using SPSS 17. Majority of the sinonasal tumors were squamous cell carcinomas involving the maxillary sinus. Locoregional recurrence was found to be more frequent in patients with positive neck nodes on final histopathology. Sinonasal malignancies are mostly squamous cell in variety and recurrence of these rare entities is dependent on the histological variety and the presence of positive neck nodes.
Keywords: Locoregional recurrence; Positive neck nodes; Sinonasal malignancy; Squamous cell carcinoma.
Figures
Similar articles
-
A comprehensive comparative analysis of treatment modalities for sinonasal malignancies.Cancer. 2017 Aug 15;123(16):3040-3049. doi: 10.1002/cncr.30686. Epub 2017 Apr 3. Cancer. 2017. PMID: 28369832 Free PMC article.
-
INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.Oncologist. 2020 Sep;25(9):738-744. doi: 10.1634/theoncologist.2019-0830. Epub 2020 Jun 12. Oncologist. 2020. PMID: 32337786 Free PMC article.
-
Imaging Characteristics of Malignant Sinonasal Tumors.J Clin Med. 2017 Dec 6;6(12):116. doi: 10.3390/jcm6120116. J Clin Med. 2017. PMID: 29211048 Free PMC article. Review.
-
Biphenotypic Sinonasal Sarcoma.2023 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2023 Feb 26. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 36943968 Free Books & Documents.
-
Clinical management of emerging sinonasal malignancies.Head Neck. 2020 Aug;42(8):2202-2212. doi: 10.1002/hed.26150. Epub 2020 Mar 25. Head Neck. 2020. PMID: 32212360 Review.
Cited by
-
The pterygopalatine fossa: imaging anatomy, communications, and pathology revisited.Insights Imaging. 2016 Aug;7(4):589-99. doi: 10.1007/s13244-016-0498-1. Epub 2016 May 26. Insights Imaging. 2016. PMID: 27230518 Free PMC article. Review.
-
Characterization of the tumor immune microenvironment of sinonasal squamous-cell carcinoma.Int Forum Allergy Rhinol. 2022 Jan;12(1):39-50. doi: 10.1002/alr.22867. Epub 2021 Sep 12. Int Forum Allergy Rhinol. 2022. PMID: 34510766 Free PMC article.
-
Locally advanced paranasal sinus carcinoma: A study of 30 patients.Oncol Lett. 2017 Mar;13(3):1338-1342. doi: 10.3892/ol.2017.5598. Epub 2017 Jan 11. Oncol Lett. 2017. PMID: 28454258 Free PMC article.
-
Treatment Outcomes of Maxillary Sinus Squamous Cell Carcinoma at a Dedicated Cancer Institute: A Retrospective Study.Cureus. 2022 Jun 3;14(6):e25644. doi: 10.7759/cureus.25644. eCollection 2022 Jun. Cureus. 2022. PMID: 35795498 Free PMC article.
-
Dysregulation of Translation Factors EIF2S1, EIF5A and EIF6 in Intestinal-Type Adenocarcinoma (ITAC).Cancers (Basel). 2021 Nov 11;13(22):5649. doi: 10.3390/cancers13225649. Cancers (Basel). 2021. PMID: 34830804 Free PMC article.
References
-
- AJCC Cancer Staging Manual. 6. New York: Springer; 2003.
-
- Mattavelli CG, Pizzi N, Podrecca S, Valentini V. Malignant maxillary tumors involving the pterygo-maxillary and infratemporal fossae: a series of 65 patients and a comparison of the 1997 and 1977 UICC-AJCC staging systems. Acta Otorhinolaryngol Ital. 2000;20:100–105. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources